UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
January 20, 2022
001-36686
(Commission file number)
Forward Pharma A/S
(Translation of registrant’s name into English)
Østergade 24A, 1st Floor
1100 Copenhagen K, Denmark
(Address of principal executive office)
________________________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes [ ] No [ X ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes [ ] No [ X ]
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes [ ] No [ X ]
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
Item 1. Other Items
On January 20, 2022, Forward Pharma A/S commenced mailing letters to holders of its ordinary shares, warrants and deferred shares regarding the conversion of ordinary shares into American Depositary Shares, copies of which are attached hereto as Exhibits 99.1, 99.2 and 99.3, respectively.
EXHIBIT INDEX
Exhibit No. | Description |
99.1 | Letter to Holders of Ordinary Shares |
99.2 | Letter to Holders of Warrants |
99.3 | Letter to Holders of Deferred Shares |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: January 20, 2022 | Forward Pharma A/S | ||
By: | /s/ Claus Bo Svendsen | ||
Name: Claus Bo Svendsen | |||
Title: Chief Executive Officer |